Science Times: Phase I/II Trial of Combination of Temozolomide Chemotherapy and Immunotherapy With Fusions of Dendritic and Glioma Cells in Patients With Glioblastoma

Standard treatment for newly diagnosed glioblastoma multiforme (GBM) includes surgical resection, followed by adjuvant radiation and concurrent temozolomide (TMZ) chemotherapy. Almost invariably, GBM acquires resistance to TMZ, resulting in tumor […]

Read Article →

Science Times: Thrombolytic Removal of Intraventricular Hemorrhage in Treatment of Severe Stroke: Results of the Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III Trial

Intracerebral hemorrhage is a devastating cause of morbidity and mortality, affecting between 37 000 and 52 400 patients annually in the United States.1Patients with intraventricular hemorrhage (IVH) extension have a […]

Read Article →